Last reviewed · How we verify

NCT05021289

Guided Imagery on the Perceived Stress Level in High-Risk Pregnancies

Completed NA Last updated 31 August 2021
What this trial tests

NA trial testing guided imagery in High Risk Pregnancy in 128 participants. Completed in 1 May 2021.

Timeline
1 February 2021
Primary endpoint
1 February 2021
1 May 2021

Quick facts

Lead sponsorNursel Alp Dal
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposesupportive care
Enrollment128
Start date1 February 2021
Primary completion1 February 2021
Estimated completion1 May 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Nursel Alp Dal

Who can join

18 and older, female only, with High Risk Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research was conducted to identify the effect of the practice of Guided Imagery on the perceived stress level in high-risk pregnancies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of guided imagery

Trials testing the same drug.

Other recruiting trials for High Risk Pregnancy

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05021289.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing